Physician profile
Sara Yang
NPI 1225569163
$7,028.90
in general payments reported to CMS, 2019-2025
11 companies · $4,033 in 2025
The $4,033 reported for 2025 was more than what 94% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $52.71 · 2021: $173 · 2022: $774 · 2023: $120 · 2024: $1,721 · 2025: $4,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,399 · Honoraria: $2,000 · Food and Beverage: $1,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,398.72 |
| Honoraria | $2,000.00 |
| Food and Beverage | $1,475.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $2,553.65 | 2024-2025 | |
| Axogen | $1,263.50 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Medical Device Business Services, INC. | $1,225.77 | 2025 | Matrixcombo |
| Stryker Corporation | $468.57 | 2020-2024 | Na, Sdc3 |
| Depuy Synthes Sales INC. | $415.50 | 2022-2025 | Trumatch, Matrixmandible, Matrixmidface |
| Baxter Healthcare | $392.62 | 2022-2024 | |
| Integra Lifesciences Corporation | $186.79 | 2022 | |
| Kerecis Limited | $175.53 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Intersect Ent, INC. | $154.92 | 2019 | |
| Polynovo North America LLC | $137.06 | 2022-2025 | Novosorb Btm |
| Alk-Abello, INC | $54.99 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.